全文获取类型
收费全文 | 14986篇 |
免费 | 1052篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 191篇 |
儿科学 | 402篇 |
妇产科学 | 252篇 |
基础医学 | 2058篇 |
口腔科学 | 405篇 |
临床医学 | 1929篇 |
内科学 | 2622篇 |
皮肤病学 | 161篇 |
神经病学 | 1506篇 |
特种医学 | 523篇 |
外科学 | 1665篇 |
综合类 | 173篇 |
一般理论 | 8篇 |
预防医学 | 1749篇 |
眼科学 | 338篇 |
药学 | 1034篇 |
中国医学 | 23篇 |
肿瘤学 | 1035篇 |
出版年
2023年 | 119篇 |
2022年 | 167篇 |
2021年 | 334篇 |
2020年 | 228篇 |
2019年 | 332篇 |
2018年 | 392篇 |
2017年 | 296篇 |
2016年 | 334篇 |
2015年 | 386篇 |
2014年 | 480篇 |
2013年 | 712篇 |
2012年 | 1059篇 |
2011年 | 1134篇 |
2010年 | 556篇 |
2009年 | 539篇 |
2008年 | 914篇 |
2007年 | 950篇 |
2006年 | 990篇 |
2005年 | 957篇 |
2004年 | 818篇 |
2003年 | 785篇 |
2002年 | 775篇 |
2001年 | 163篇 |
2000年 | 121篇 |
1999年 | 148篇 |
1998年 | 145篇 |
1997年 | 144篇 |
1996年 | 110篇 |
1995年 | 102篇 |
1994年 | 86篇 |
1993年 | 93篇 |
1992年 | 93篇 |
1991年 | 114篇 |
1990年 | 90篇 |
1989年 | 96篇 |
1988年 | 77篇 |
1987年 | 69篇 |
1986年 | 67篇 |
1985年 | 75篇 |
1984年 | 68篇 |
1983年 | 83篇 |
1982年 | 79篇 |
1981年 | 84篇 |
1980年 | 68篇 |
1979年 | 55篇 |
1978年 | 43篇 |
1977年 | 49篇 |
1976年 | 49篇 |
1974年 | 42篇 |
1972年 | 37篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
Lorraine N Clark Eneli Haamer Helen Mejia-Santana Juliette Harris Suzanne Lesage Alexandra Durr Sabine Janin Bs Katja Hedrich Elan D Louis Lucien J Cote Howard Andrews Stanley Fahn Cheryl Waters Blair Ford Steven Frucht William Scott Christine Klein Alexis Brice Hanno Roomere Ruth Ottman Karen Marder 《Movement disorders》2007,22(7):932-937
Parkin mutations account for the majority of familial and sporadic early onset Parkinson's disease (EOPD) cases with a known genetic association. More than 100 mutations have been described in the Parkin gene that includes homozygous, compound heterozygous, and single heterozygous mutations. We have designed a Parkin mutation genotyping array (gene chip) that includes published Parkin sequence variants and allows their simultaneous detection. The chip was validated by screening 85 PD cases and 47 controls previously tested for Parkin mutations. Similar genotyping microarrays have been developed for other genetically heterogeneous diseases including age-related macular degeneration. Here, we show the utility of a genotyping array for Parkinson's disease by analysis of 60 subjects from the Genetic Epidemiology of Parkinson Disease (GEPD) study that includes 15 early-onset PD case probands and 45 relatives. 相似文献
32.
33.
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is frustrating for both clinicians and patients. The prostate is not scientifically proven to cause the symptoms of CP/CPPS, yet the prostate continues to be the diagnosis of convenience in this complex syndrome in men. However, if the pain is not of prostatic origin, what causes it? A heterogeneous group of insults can result in a common neurogenic pain response, resulting in recurring pain and voiding or sexual dysfunction. To add to this dilemma, certain life-threatening diagnoses, such as carcinoma-in-situ, are in the differential diagnosis and must be excluded. Urodynamics may be useful in evaluating and treating patients whose voiding symptoms predominate, such as those with concomitant overactive bladder symptoms. However, many patients with CP/CPPS will not have measurable abnormalities by conventional methods and likely suffer from a functional somatic syndrome that is best treated with a multimodality approach. 相似文献
34.
35.
36.
Daniel L. Rubin Karen L. Falk Malcolm J. Sperling Michael Ross Sanjay Saini Barry Rothman Frank Shellock Elias Zerhouni David Stark Eric K. Outwater Udo Schmiedl Louis C. Kirby Judith Chezmar Terry Coates Miles Chang Jeffery M. Silverman Neil Rofsky Keith Burnett Julie Engel Stuart W. Young 《Journal of magnetic resonance imaging : JMRI》1997,7(5):865-872
The purpose of this study was to assess the effectiveness and safety of Gadolite Oral Suspension as a gastrointestinal (GI) contrast agent for MRI in a phase II and two phase III multicenter clinical trials. Gadolite was administered to 306 patients with known or suspected abdominal and/or pelvic disease. MRI with T1- and T2-weighted sequences was performed before and after ingestion. Efficacy was evaluated by having two masked readers rate the certainty of their MR diagnosis (0 = uncertain, 1 = probable, 2 = definite) on randomly presented pre- and post-Gadolite Oral Suspension enhanced images. Principal investigators also evaluated the images and established the final diagnosis. Vital signs, clinical chemistries, and adverse events were documented. Blood and urine samples were analyzed for gadolinium content to determine whether Gadolite Oral Suspension was absorbed systemically. Certainty in MR diagnosis increased significantly (P < .001) for both blinded readers between pre- and post-Gadolite images (.49–1.18 for reader 1; .46–1.53 for reader 2). Sensitivity, specificity, and accuracy also increased for both masked readers. No gadolinium was detected in blood or urine samples. There were no serious adverse events and no apparent drug-related trends in mean vital signs or laboratory values. Gadolite is a highly effective, safe, and well tolerated contrast agent for clinical use with MRI. 相似文献
37.
38.
Vagus Nerve Stimulation Induces a Sustained Anticonvulsant Effect 总被引:17,自引:11,他引:6
Summary: Purpose: Stimulation of the vagus nerve can effectively abort several types of experimentally induced seizures in animals when administered near the time of seizure onset. Indirect evidence from human trials and animal studies suggests that the anticonvulsant effects of vagus nerve stimulation (VNS) extend beyond the duration of stimulation. We used the pentylenetetrazol model to determine whether VNS exerts a persistent anticonvulsant effect.
Methods: VNS (1 mA, 30 Hz, 500 μs pulse width) was administered continuously for 0, 1, or 60 min, or intermittently (30 s on, 5 min off) for 60 min, to awake and freely moving animals. After the end of stimulation, pentylenetetrazol (50 mg/kg i.p.) was administered to induce seizures. Time-course studies were also performed, consisting of 60 min of VNS followed by pentylenetetrazol injection after 0, 3-, 5-, and 10-min intervals.
Results: The greatest anticonvulsant effect occurred after 60 min of continuous VNS, which prevented convulsions in four of 12 rats and reduced significantly seizure duration, the total number of seizures, and number of tonic seizures. Intermittent VNS was less effective than continuous stimulation for 60 min, but more effective than that for 1 min. The anticonvulsant effect declined in a time-dependent fashion after discontinuation of VNS, with return to nonstimulated control values by 10 min.
Conclusions: The results of this study verify a persistent VNS-induced anticonvulsant effect and indicate that its efficacy is dependent on the cumulative stimulus duration. 相似文献
Methods: VNS (1 mA, 30 Hz, 500 μs pulse width) was administered continuously for 0, 1, or 60 min, or intermittently (30 s on, 5 min off) for 60 min, to awake and freely moving animals. After the end of stimulation, pentylenetetrazol (50 mg/kg i.p.) was administered to induce seizures. Time-course studies were also performed, consisting of 60 min of VNS followed by pentylenetetrazol injection after 0, 3-, 5-, and 10-min intervals.
Results: The greatest anticonvulsant effect occurred after 60 min of continuous VNS, which prevented convulsions in four of 12 rats and reduced significantly seizure duration, the total number of seizures, and number of tonic seizures. Intermittent VNS was less effective than continuous stimulation for 60 min, but more effective than that for 1 min. The anticonvulsant effect declined in a time-dependent fashion after discontinuation of VNS, with return to nonstimulated control values by 10 min.
Conclusions: The results of this study verify a persistent VNS-induced anticonvulsant effect and indicate that its efficacy is dependent on the cumulative stimulus duration. 相似文献
39.
H(1)-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. 总被引:1,自引:0,他引:1
Andrew J Goudie Jason C G Halford Terry M Dovey Gillian D Cooper Joanna C Neill 《Neuropsychopharmacology》2003,28(12):2209; author reply 2210-2209; author reply 2211
40.